Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multi-Center Randomized Study to Evaluate the Effects of Carvedilol on Cardiotoxicity in Cancer Patients Submitted to Anthracycline Therapy

NCT04939883 is registered in ClinicalTrials.gov with Hospital Sirio-Libanes as lead sponsor.

NCT NCT04939883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04939883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multi-Center Randomized Study to Evaluate the Effects of Carvedilol on Cardiotoxicity in Cancer Patients Submitted to Anthracycline Therapy
Lead sponsor
Hospital Sirio-Libanes
Phase
Phase 4
Overall status
Active, not recruiting
Start date
August 1, 2021
Completion date
May 31, 2027
Enrollment
1,018 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer